These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19332209)

  • 1. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.
    Hage FG; Heo J; Franks B; Belardinelli L; Blackburn B; Wang W; Iskandrian AE
    Am Heart J; 2009 Apr; 157(4):771-6. PubMed ID: 19332209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome.
    Hage FG; Perry G; Heo J; Iskandrian AE
    Am J Cardiol; 2010 Mar; 105(6):839-43. PubMed ID: 20211328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.
    Hage FG; Dean P; Bhatia V; Iqbal F; Heo J; Iskandrian AE
    Am Heart J; 2011 Aug; 162(2):356-62. PubMed ID: 21835298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of regadenoson for measurement of fractional flow reserve.
    Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate response to adenosine in patients with diabetes mellitus and normal myocardial perfusion imaging.
    Bravo PE; Hage FG; Woodham RM; Heo J; Iskandrian AE
    Am J Cardiol; 2008 Oct; 102(8):1103-6. PubMed ID: 18929717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats.
    Dhalla AK; Wong MY; Wang WQ; Biaggioni I; Belardinelli L
    J Pharmacol Exp Ther; 2006 Feb; 316(2):695-702. PubMed ID: 16227469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.
    Iqbal FM; Al Jaroudi W; Sanam K; Sweeney A; Heo J; Iskandrian AE; Hage FG
    Am J Cardiol; 2013 Jan; 111(2):190-5. PubMed ID: 23111139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regadenoson: a new myocardial stress agent.
    Al Jaroudi W; Iskandrian AE
    J Am Coll Cardiol; 2009 Sep; 54(13):1123-30. PubMed ID: 19761931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regadenoson.
    Garnock-Jones KP; Curran MP
    Am J Cardiovasc Drugs; 2010; 10(1):65-71. PubMed ID: 20063904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.
    Jahnke C; Nagel E; Gebker R; Kokocinski T; Kelle S; Manka R; Fleck E; Paetsch I
    Circulation; 2007 Apr; 115(13):1769-76. PubMed ID: 17353441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.
    Zhao G; Messina E; Xu X; Ochoa M; Sun HL; Leung K; Shryock J; Belardinelli L; Hintze TH
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):369-75. PubMed ID: 17577101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function.
    Gordi T; Blackburn B; Lieu H
    J Clin Pharmacol; 2007 Jul; 47(7):825-33. PubMed ID: 17585115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging.
    Thomas DM; Minor MR; Aden JK; Lisanti CJ; Steel KE
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):96. PubMed ID: 29202847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of diabetes mellitus on left ventricular function in patients undergoing coronary artery bypass grafting.
    Sugioka J; Ozawa S; Inagaki M; Fukuzawa S; Daimon M; Kushida S; Tateno K
    J Cardiol; 2000 Jul; 36(1):9-16. PubMed ID: 10929261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of functional status after coronary artery bypass grafting in patients with and without diabetes mellitus.
    Sahakyan K; Abramson JL; Krumholz HM; Vaccarino V
    Am J Cardiol; 2006 Sep; 98(5):619-23. PubMed ID: 16923448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    Andrikopoulou E; AlJaroudi WA; Farag A; Lester D; Patel H; Iskandrian AE; Hage FG
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1493-502. PubMed ID: 27079736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.